查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613051

秋水仙鹼市場：按劑型、年齡、給藥途徑、銷售管道、應用 - 全球預測 2025-2030

Colchicine Market by Dosage Formulation (Liquid, Semisolid Gel, Solid), Age (Adult, Children, Senior), Route of Administration, Sales Channels, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年秋水仙鹼市場價值為14.6億美元，預計到2024年將達到15.8億美元，複合年成長率為7.85%，預計到2030年將達到24.9億美元。

秋水仙鹼是一種成熟的藥物，主要用於治療和管理痛風和遺傳性地中海熱等疾病。它的適用性擴展到其他領域，例如心膜炎和心血管疾病的潛在用途，表明其影響範圍正在擴大。秋水仙鹼的需求在於其在減輕發炎和疼痛方面的有效性，特別是在替代藥物有限或具有顯著副作用的慢性疾病中。最終用途範圍主要包括醫院、診所和居家醫療機構，用於管理需要長期治療的疾病。秋水仙鹼市場受到全球痛風和發炎疾病盛行率不斷上升、人口老化加劇以及對其潛在心臟益處的持續研究等因素的影響。此外，對秋水仙鹼新治療應用的認可為相關人員提供了投資擴大研究和開發的絕佳機會，旨在發現新的治療範例和配方創新。然而，挑戰依然存在，包括嚴格的法律規範、需要仔細醫療管理的潛在副作用，以及可能威脅市場佔有率的新型發炎藥物的競爭。尤其是給藥系統的技術創新潛力巨大，可望提高患者用藥依從性、減少副作用，同時也有可能透過循環系統領域的廣泛研究發現新的適應症。該市場的特點是成熟，但由於新的應用和配方的進步，具有快速成長的潛力。為了利用新機遇，投資研究並與醫療機構合作可以提供競爭優勢。同時，公司必須透過確保合規性、患者安全以及向醫療保健專業人員和患者有效傳達藥物來克服挑戰。

主要市場統計
基準年[2023] 14.6億美元
預測年份 [2024] 15.8億美元
預測年份 [2030] 24.9億美元
複合年成長率（%） 7.85%

市場動態：揭示快速發展的秋水仙鹼市場的關鍵市場洞察

供需的動態交互作用正在改變秋水仙鹼市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球痛風和心血管疾病盛行率上升
    • 新研究顯示秋水仙鹼治療其他發炎疾病的潛力
    • 心血管疾病管理的需求不斷增加
  • 市場限制因素
    • FDA核准的製造商數量有限
  • 市場機會
    • 緩釋性與聯合治療的開發
    • 增加研發投資以提高藥物生物利用度、減少副作用並提高病患依從性
  • 市場挑戰
    • 確保病患安全和有效性的監管狀況

波特的五力：駕馭秋水仙鹼市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解秋水仙鹼市場的外部影響

外部宏觀環境因素對秋水仙鹼市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解秋水仙鹼市場的競爭狀況

對秋水仙鹼市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣秋水仙鹼市場供應商績效評估

FPNV定位矩陣是評估秋水仙鹼市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了秋水仙鹼市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，秋水仙鹼市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球痛風和心血管疾病盛行率上升
      • 新研究顯示秋水仙鹼可能有效治療其他發炎疾病
      • 心血管疾病管理的需求日益增加
    • 抑制因素
      • FDA核准的製造商數量有限
    • 機會
      • 緩釋性或聯合治療的開發
      • 增加研發投資，以提高藥物生物有效性、減少副作用並增強病患依從性
    • 任務
      • 確保病患安全和有效性的監管狀況
  • 市場區隔分析
    • 劑量配方：秋水仙鹼錠劑的易用性、穩定性和廣泛可用性
    • 應用：提高秋水仙鹼治療痛風的療效和安全性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 秋水仙鹼市場依劑量處方

  • 液體
  • 半固體凝膠
  • 固體的

第7章依年齡分類的秋水仙鹼市場

  • 成人用
  • 孩子們
  • 進階的

第8章秋水仙鹼市場：依給藥途徑分類

  • 口服
  • 話題

第9章秋水仙鹼市場依銷售管道分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章秋水仙鹼市場：依應用分類

  • 光化性角化症
  • 白塞氏症
  • 皰疹性皮膚炎
  • 遺傳性地中海熱
  • 痛風
  • 柏哲氏病

第11章 美洲秋水仙鹼市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區秋水仙鹼市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲秋水仙鹼市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Endo 推出 Mitigare非專利藥“秋水仙鹼膠囊”
    • Agefa Pharma 的秋水仙鹼獲得 FDA核准，秋水仙鹼是一種治療心臟病的古老痛風療法
  • 戰略分析和建議

公司名單

  • AGEPHA Pharma USA, LLC
  • Alchem International Pvt Ltd
  • Ascend Laboratories, LLC
  • Aurobindo Pharma Limited
  • Bio-Techne Corporation
  • bioWORLD by GeneLinx International, Inc.
  • Camber Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Endo International PLC
  • EURO-PHARM International Canada Inc.
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • Hikma Pharmaceuticals
  • Indena SpA
  • LGM Pharma
  • Odan Laboratories Ltd
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Vital Laboratories Private Limited
Product Code: MRR-351BAD503AE4

The Colchicine Market was valued at USD 1.46 billion in 2023, expected to reach USD 1.58 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 2.49 billion by 2030.

Colchicine is a well-established medication primarily used for the treatment and management of conditions such as gout and familial Mediterranean fever. Its applicability extends into other areas like pericarditis and potential uses in cardiovascular diseases, indicating a broadening scope. The necessity for colchicine is driven by its effectiveness in reducing inflammation and pain, especially in chronic conditions where alternatives may be limited or have significant side effects. The end-use scope predominantly includes hospitals, clinics, and home care settings where patients manage conditions requiring long-term treatment. The market for colchicine is influenced by factors such as the increasing global prevalence of gout and inflammatory diseases, a growing aging population, and ongoing research into its potential cardiac benefits. Additionally, awareness of colchicine's applications in new therapeutic areas presents potent opportunities for stakeholders to invest in expanded research and development, aiming to uncover new treatment paradigms and formulation innovations. However, challenges persist, including stringent regulatory frameworks, potential side effects requiring cautious medical supervision, and competition from newer anti-inflammatory drugs that may threaten market share. There exists significant potential for innovation particularly in drug delivery systems, which could improve patient adherence and reduce side effects, as well as possible new indications discovered through extensive research in the cardiovascular domain. The nature of the market is characterized by its mature standing with potential spurts of growth driven by novel applications and formulation advancements. To capitalize on emerging opportunities, investing in research and collaborative efforts with healthcare institutions could provide a competitive edge. Meanwhile, companies must navigate challenges by ensuring compliance, patient safety, and effective communication of the drug's benefits to healthcare providers and patients.

KEY MARKET STATISTICS
Base Year [2023] USD 1.46 billion
Estimated Year [2024] USD 1.58 billion
Forecast Year [2030] USD 2.49 billion
CAGR (%) 7.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Colchicine Market

The Colchicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of gout and cardiovascular diseases globally
    • Emerging research suggesting the potential of colchicine in treating other inflammatory diseases
    • Growing need of cardiovascular disease management
  • Market Restraints
    • Limited number of FDA-approved manufacturers
  • Market Opportunities
    • Developing sustained-release formulations or combination therapies
    • Rising investment in R&D to improving the drug's bioavailability, reducing its side effects, and enhancing patient compliance
  • Market Challenges
    • Regulatory landscape ensuring patient safety and efficacy

Porter's Five Forces: A Strategic Tool for Navigating the Colchicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Colchicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Colchicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Colchicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Colchicine Market

A detailed market share analysis in the Colchicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Colchicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Colchicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Colchicine Market

A strategic analysis of the Colchicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Colchicine Market, highlighting leading vendors and their innovative profiles. These include AGEPHA Pharma USA, LLC, Alchem International Pvt Ltd, Ascend Laboratories, LLC, Aurobindo Pharma Limited, Bio-Techne Corporation, bioWORLD by GeneLinx International, Inc., Camber Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Endo International PLC, EURO-PHARM International Canada Inc., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., Hikma Pharmaceuticals, Indena S.p.A., LGM Pharma, Odan Laboratories Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Vital Laboratories Private Limited.

Market Segmentation & Coverage

This research report categorizes the Colchicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Dosage Formulation, market is studied across Liquid, Semisolid Gel, and Solid.
  • Based on Age, market is studied across Adult, Children, and Senior.
  • Based on Route of Administration, market is studied across Oral and Topical.
  • Based on Sales Channels, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Application, market is studied across Actinic Keratosis, Behcet's Disease, Dermatitis Herpetiformis, Familial Mediterranean Fever, Gout, and Paget's Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of gout and cardiovascular diseases globally
      • 5.1.1.2. Emerging research suggesting the potential of colchicine in treating other inflammatory diseases
      • 5.1.1.3. Growing need of cardiovascular disease management
    • 5.1.2. Restraints
      • 5.1.2.1. Limited number of FDA-approved manufacturers
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing sustained-release formulations or combination therapies
      • 5.1.3.2. Rising investment in R&D to improving the drug's bioavailability, reducing its side effects, and enhancing patient compliance
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory landscape ensuring patient safety and efficacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Dosage Formulation: Ease of use, stability, and widespread availability of colchicine tablets
    • 5.2.2. Application: Improved efficacy and safety of colchicine in gout treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Colchicine Market, by Dosage Formulation

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Semisolid Gel
  • 6.4. Solid

7. Colchicine Market, by Age

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Children
  • 7.4. Senior

8. Colchicine Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Topical

9. Colchicine Market, by Sales Channels

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Colchicine Market, by Application

  • 10.1. Introduction
  • 10.2. Actinic Keratosis
  • 10.3. Behcet's Disease
  • 10.4. Dermatitis Herpetiformis
  • 10.5. Familial Mediterranean Fever
  • 10.6. Gout
  • 10.7. Paget's Disease

11. Americas Colchicine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Colchicine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Colchicine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Endo Launches Colchicine Capsules, Generic Version of MITIGARE
    • 14.3.2. Agepha Pharma gets ancient gout remedy colchicine across the FDA finish line for heart disease
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AGEPHA Pharma USA, LLC
  • 2. Alchem International Pvt Ltd
  • 3. Ascend Laboratories, LLC
  • 4. Aurobindo Pharma Limited
  • 5. Bio-Techne Corporation
  • 6. bioWORLD by GeneLinx International, Inc.
  • 7. Camber Pharmaceuticals, Inc.
  • 8. Dr. Reddy's Laboratories Ltd.
  • 9. Endo International PLC
  • 10. EURO-PHARM International Canada Inc.
  • 11. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • 12. Hikma Pharmaceuticals
  • 13. Indena S.p.A.
  • 14. LGM Pharma
  • 15. Odan Laboratories Ltd
  • 16. Pfizer Inc.
  • 17. Takeda Pharmaceutical Company Limited
  • 18. Teva Pharmaceutical Industries Ltd.
  • 19. Vital Laboratories Private Limited

LIST OF FIGURES

  • FIGURE 1. COLCHICINE MARKET RESEARCH PROCESS
  • FIGURE 2. COLCHICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. COLCHICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLCHICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COLCHICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COLCHICINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLCHICINE MARKET SIZE, BY SEMISOLID GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COLCHICINE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COLCHICINE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLCHICINE MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COLCHICINE MARKET SIZE, BY SENIOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLCHICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COLCHICINE MARKET SIZE, BY ACTINIC KERATOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COLCHICINE MARKET SIZE, BY BEHCET'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COLCHICINE MARKET SIZE, BY DERMATITIS HERPETIFORMIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COLCHICINE MARKET SIZE, BY PAGET'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. COLCHICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2023